Mary Kay

Last updated January 21, 2026

Innovation Areas

117

Inventors

Collaborations

Anti-inflammatory topical phytochemical formulations: Mary KayRecent Research Landscape

The engineering of specific bioactive concentrations within topical vehicles to modulate cutaneous vascular response. This provides clinical differentiation by targeting the physiological pathways of erythema and rosacea.

What technical problems is Mary Kay addressing in Anti-inflammatory topical phytochemical formulations?

Excessive facial microvascular dilation

(3)evidences

The cluster addresses the chronic vascular dilation and inflammation associated with rosacea. Resolving this provides a therapeutic advantage over general skincare by targeting specific microvascular dysfunction.

Cutaneous hyperreactivity to exogenous stimuli

(2)evidences

The cluster targets the physiological intolerance and inflammatory response of compromised skin barriers. Addressing this limitation allows for the use of active ingredients without triggering adverse sensory or immunological reactions.